from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1115/-

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

0.436

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.876

Rif0.2-5ug/mL Rifampicintranscription

-0.454

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.558

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.207

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.199

CPZ10-50 ug/mL Chlorpromazinerespiration

0.713

Clofazimine10-13 ug/mL Clofaziminerespiration

0.155

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.479

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.661

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.118

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.295

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.982

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.137

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.226

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.972

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.976

KCN5-20 ug/mL Potassium cyaniderespiration

0.332

NaN30.2-2 mM Sodium aziderespiration

-0.128

Nigericin50 uM Nigericinrespiration

-0.316

TRC10-150 ug/mL Triclosanrespiration

-0.887

TRZ10-25 ug/mL Thioridazinerespiration

-0.240

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.781

menadione6-10 ug/mL Menadionerespiration

0.899

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-2.206

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.195

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.221

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.001

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.207

Cephalexin20-100 ug/mL CephalexincellWall

-0.247

Cerulenin0.32-5 ug/mL CerulenincellWall

0.547

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.399

EMB10-20 ug/mL EthambutolcellWall

-0.270

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.790

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.790

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.938

BZA0.12 mg/mL BenzamidearomaticAmides

0.238

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.255

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.931

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.514

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.479

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.999

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.478

UVUV-irradiationDNAdamaging

-0.443

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.941

Antimycin12.5-50 ug/mL Antimycin A?

-0.379

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.150

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.689

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.218

PA8240.2-2 ug/mL PA-824?

1.833

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.211

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.576

Verapamil50 uM Verapamil?

-0.526

mercaptoethanol2 mM 2-Mercaptoethanol?

0.388

methoxatin10-20 ug/mL Methoxatin?